Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCaris Life Sciences, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Caris Life Sciences, Inc.

$31.47Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q2 ’262023202420252026-100M0100M200M300MLatest period Q2 '26. Revenue 263.71M. Gross profit 179.6M. Net profit -637K.
RevenueGross profitNet profit
See which business lines, products, or regions generate the company’s sales.Formula: Company revenue = Σ(segment revenues) + reconciliation adjustments
Q2 ’262023202420252026050M100M150M200M250MLatest period Q2 '26. Molecular Profiling Services 252.25M. Pharma Research And Development Services 11.46M.
Molecular Profiling ServicesPharma Research And Development Services
See how much of the company’s revenue comes from each customer it reports as 10% or more of revenue. Filings often name these customers only as Customer A, Customer B, and so on.Formula: Customer share = customer revenue ÷ total revenue × 100% Other customers = 100% − Σ(major customer shares)
Q2 ’2620232024202520260%20%40%60%80%100%
      Latest period Q2 '26. Commercial Payer One 37.3%. Commercial Payer Two 12.6%. Commercial Payer Three 15.6%. Other customers 34.5%.
      Commercial Payer OneCommercial Payor OneCommercial Payer TwoCommercial Payor TwoCommercial Payer ThreeCommercial Payor ThreeOther customers
      See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
      Q2 ’262023202420252026-50%0%50%Latest period Q2 '26. Gross margin 68.1%. Operating margin 10.2%. Net profit margin -0.2%.
      Gross marginOperating marginNet profit margin
      Revenue the company expects from promised goods or services it still needs to deliver under customer contracts.
      Q2 ’26202320242025202605M10M15M
          Latest period Q2 '26. Remaining performance obligations 17.2M.
          Remaining performance obligations
          See the amounts the company has committed to pay that its balance sheet does not record yet: leases it has signed that have not started, unconditional purchase and other contractual commitments, and the most it could have to pay under guarantees and credit backstops. Amounts are as the filing reports them at each balance-sheet date.Formula: Commitments = leases not yet commenced + purchase & other commitments + maximum guarantee exposure
          Q4 ’25202320242025010M20M30M40M50M
              Latest period Q4 '25. Leases not yet commenced 17.6M. Purchase & other commitments 33.7M.
              Leases not yet commencedPurchase & other commitmentsGuarantees & contingent commitments
              Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
              $
              Q2 ’262023202420252026-60M-40M-20M020M40M60M
                • Capex: purchases of property, plant and equipment
                • Capex: purchases of property, plant and equipment
                • Capex: purchases of property, plant and equipment
                • Capex: purchases of property, plant and equipment
                • Capex: purchases of property, plant and equipment
                Latest period Q2 '26. Operating cash flow 28.5M. Free cash flow 6.4M.
                Operating cash flowCapexFree cash flow
                Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
                20262023202420250200M400M600M800M
                    Latest period 2026. Cash 819.9M. Debt 381.6M.
                    CashDebtNet cash
                    Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
                    $/shareUsing split history cached 2026-09-23; assuming no new splits
                    four_consecutive_quarters_unavailableMissingfour_consecutive_quarters_unavailableMissingQ2 ’262023202420252026-10.00-8.00-6.00-4.00-2.000.00
                    • Q2 2024: four consecutive quarters unavailable
                    • Q3 2024: four consecutive quarters unavailable
                    • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2026-02-26: 282,579,919 source shares. Uses later-dated shares from the same quarterly filing.
                    • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: unavailable source shares.
                    • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: unavailable source shares.
                    • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 36,504,319 source shares.
                    • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2026-05-05: 282,680,695 source shares. Uses later-dated shares from the same quarterly filing.
                    • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 281,090,538 source shares.
                    • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 282,103,259 source shares.
                    • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 282,526,097 source shares.
                    • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 282,650,723 source shares.
                    • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 282,582,915 source shares.
                    Latest period Q2 2026. EPS (TTM) 0.37.
                    EPS (TTM)
                    How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
                    Using split history cached 2026-09-23; assuming no new splits
                    four consecutive quarters unavailableMissingfour consecutive quarters unavailableMissinghistorical price missing or staleMissingQ2 ’2620232024202520260x20x40x
                    • Q2 2024: four consecutive quarters unavailable
                    • Q3 2024: four consecutive quarters unavailable
                    • FY 2024: historical price missing or stale
                    • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2026-02-26: 282,579,919 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2026-02-27.
                    • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: unavailable source shares.
                    • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: unavailable source shares.
                    • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 36,504,319 source shares.
                    • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2026-05-05: 282,680,695 source shares. Uses later-dated shares from the same quarterly filing. Nearby weekly price on 2026-05-08.
                    • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 281,090,538 source shares. Nearby weekly price on 2025-06-27.
                    • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 282,103,259 source shares. Nearby weekly price on 2025-10-03.
                    • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 282,526,097 source shares. Nearby weekly price on 2026-01-02.
                    • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 282,650,723 source shares. Nearby weekly price on 2026-04-02.
                    • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 282,582,915 source shares. Nearby weekly price on 2026-07-02.
                    Latest period Q2 2026. P/E ratio 49.2x.
                    P/E ratio
                    See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
                    Stock split history may be out of date.
                    20262023202420252026050M100M150M200M250M
                        Latest period 2026. Shares outstanding 282.6M. Class detail unavailable 282.6M.
                        Class detail unavailable